Article

Hesperetin Inhibits Xanthine Oxidase Activity via Altering the Protein’s Secondary Structure and Suppressing Superoxide Anion Generation

2024-04-25

Abstract excerpt

Hyperuricemia is mainly caused by the overproduction of uric acid (UA) catalyzed from xanthine by xanthine oxidase (XO) in abnormal purine metabolism in human body. There is an increasing demand for developing novel XO inhibitors of plant origins. The inhibition kinetics and type as well as actions of hesperetin against XO were investigated in vitro using multi-spectroscopic methods including UV-Vis absorption, Fo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ff5f9f3a-ae74-5068-aebe-4b26416cecef
DOI: 10.20944/preprints202404.1678.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hesperetin Inhibits Xanthine Oxidase Activity via Altering the Protein’s Secondary Structure and Suppressing Superoxide Anion GenerationDOI 10.20944/preprints202404.1678.v1Read

Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine OxidoreductaseSemantic proximity Read

<i>In-Silico</i> Analysis of Secondary Metabolites that Modulates Enzymes of Cholesterol TargetSemantic proximity Read

In vitro and in vivo inhibition of xanthine oxidase by the flowers of Chrysanthemum morifolium Ramat.Semantic proximity Read

Identification of Anastatica hierochuntica L. Methanolic Leaves Extract-Derived Metabolites Exhibiting Xanthine Oxidase Inhibitory Activities: In Vitro and in Silico ApproachesSemantic proximity Read

Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.Semantic proximity Read

Hesperidin: A promising anticancer agent from natureSemantic proximity Read

Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: Implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant.Semantic proximity Read

Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular DiseaseSemantic proximity Read

Functional characterization of human xanthine oxidase allelic variants.Semantic proximity Read

Synthetic-free compounds as the potential glycation inhibitors performed in in vitro chemical models: Molecular mechanisms and structure requirementsSemantic proximity Read

Natural mutations of human XDH promote the nitrite (NO2-)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?Semantic proximity Read

Insilico identification of a ferroportin inhibitor for the management of iron-overload condition in Beta Thalassemia major patients.Semantic proximity Read